In recent trading session, Hims & Hers Health Inc (NYSE:HIMS) saw 7.66 million shares changing hands at last check today with its beta currently measuring 1.61. Company’s recent per share price level of $32.53 trading at -$1.4 or -4.13% at last check today assigns it a market valuation of $7.23B. That most recent trading price of HIMS’s stock is at a discount of -124.35% from its 52-week high price of $72.98 and is indicating a premium of 65.57% from its 52-week low price of $11.20. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 27.17 million shares which gives us an average trading volume of 20.69 million if we extend that period to 3-months.

For Hims & Hers Health Inc (HIMS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.47. Splitting up the data highlights that, out of 13 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 5 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.21 in the current quarter.

Hims & Hers Health Inc (NYSE:HIMS) trade information

Upright in the red during last session for losing -4.13%, in the last five days HIMS remained trading in the red while hitting it’s week-highest on Tuesday, 03/11/25 when the stock touched $32.53 price level, adding 13.69% to its value on the day. Hims & Hers Health Inc’s shares saw a change of 34.53% in year-to-date performance and have moved -5.41% in past 5-day. Hims & Hers Health Inc (NYSE:HIMS) showed a performance of -25.36% in past 30-days. Number of shares sold short was 51.84 million shares which calculate 1.68 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 25.5 to the stock, which implies a fall of -27.57% to its recent value today. Analysts have been projecting 21 as a low price target for the stock while placing it at a high target of 68. It follows that stock’s current price would jump 35.44% in reaching the projected high whereas dropping to the targeted low would mean a gain of 35.44% for stock’s current value.

Hims & Hers Health Inc (HIMS) estimates and forecasts

This year revenue growth is estimated to rise 57.14% from the last financial year’s standing.

11 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 535.21M for the same. And 11 analysts are in estimates of company making revenue of 564.91M in the next quarter. Company posted 278.17M and 315.65M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 17.22% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 12.05% while estimates for its earnings growth in next 5 years are of 31.05%.

Hims & Hers Health Inc (NYSE:HIMS)’s Major holders

Insiders are in possession of 11.25% of company’s total shares while institution are holding 78.98 percent of that, with stock having share float percentage of 88.99%. Investors also watch the number of corporate investors in a company very closely, which is 78.98% institutions for Hims & Hers Health Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at HIMS for having 16.47 million shares of worth $332.55 million. And as of 2024-06-30, it was holding 7.7166 of the company’s outstanding shares.

The second largest institutional holder is BLACKROCK INC., which was holding about 14.57 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.8278 of outstanding shares, having a total worth of $294.25 million.

On the other hand, iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 12.32 shares of worth $401.0 million or 5.76% of the total outstanding shares. The later fund manager was in possession of 5.27 shares on Dec 31, 2024 , making its stake of worth around $171.55 million in the company or a holder of 2.47% of company’s stock.